Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.

By Jiri Polivka Jr., F. Janku. Pharmacology and Therapeutics, 2014

767 citations recorded by the source corpus.

Subfields: Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/e9499ed8fd62a1c839a79ca930a80c8e7d3059ee

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Rareș Drula
2. I. Berindan‐Neagoe
3. A. Atanasov
4. C. Ionescu
5. A. Irimie
6. C. Braicu
7. Mihail Buse
8. L. Raduly

Citations in the corpus

• A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer (2019, background): “While the preclinical studies constantly provide innovative molecules and complex combinations with promising results, clinical testing becomes increasingly difficult [111,112].”